Exenatide, the first GLP-1RA approved in 2005, demonstrated clinical efficacy but its low homology with human GLP-1 and gastrointestinal side effects restricted widespread use (Muttenthaler et al., 2021)
Additionally, TMAO may exacerbate the severity of CKD in rats by promoting renal tubular epithelial cell apoptosis through the activation of the ASK1-JNK pathway
Nausea is common with tirzepatide, especially during dose escalation
It also includes Lycopene for antioxidant defense, along with essential nutrients like Vitamin C, Vitamin E, and Selenium to support collagen production and skin repair
Keep an eye out for the SEKACOS logo in storesyou might just discover your next hidden gem
Results from these studies have shown that RGT-075 is generally safe and well tolerated, while preliminary efficacy data suggest its therapeutic potential may be comparable to currently approved peptide-based GLP-1 therapies